Evotec and Variant Bio partner to develop fibrosis treatments
Drug Discovery World
APRIL 24, 2024
Evotec will identify best-in-class small molecules targeting a key fibrotic pathway with strong genetic support identified by Variant Bio and progress the programme towards the selection of a clinical development candidate(s) using its R&D platform.
Let's personalize your content